Pol was Chief Medical Officer at CymaBay Therapeutics, and Chief Medical Officer at Amicus Therapeutics. Pol Boudes joined Protalix BioTherapeutics in 2024.
Pol Boudes is currently
Create your alert
to follow the career of Pol Boudes.
Pol Boudes has a Doctor of Medicine from University of Aix-Marseille.
Do you need to know more about Pol Boudes? More results.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.